cancers Review Prevention Strategies for Esophageal Cancer— An Expert Review Elisa Marabotto 1, Gaia Pellegatta 2, Afscin Djahandideh Sheijani 1 , Sebastiano Ziola 1 , Patrizia Zentilin 1, Maria Giulia De Marzo 1, Edoardo Giovanni Giannini 1 , Matteo Ghisa 3 , Brigida Barberio 3 , Marco Scarpa 4 , Imerio Angriman 4, Matteo Fassan 5, Vincenzo Savarino 1 and Edoardo Savarino 3,* 1 Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy;
[email protected] (E.M.);
[email protected] (A.D.S.);
[email protected] (S.Z.);
[email protected] (P.Z.);
[email protected] (M.G.D.M.);
[email protected] (E.G.G.);
[email protected] (V.S.) 2 Digestive Endoscopy Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Milan, Italy;
[email protected] 3 Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padova, Italy;
[email protected] (M.G.);
[email protected] (B.B.) 4 Clinica Chirurgica 1, Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128 Padova, Italy;
[email protected] (M.S.);
[email protected] (I.A.) 5 Department of Medicine (DIMED), Surgical Pathology & Cytopathology Unit, University of Padua, 35121 Padua, Italy;
[email protected] * Correspondence:
[email protected] Simple Summary: In the last decades, there has been a rapid increase in the incidence and prevalence of esophageal cancer in many countries around the world. Although several important risk factors Citation: Marabotto, E.; Pellegatta, have been identified, strong evidence-based preventive strategies are still lacking, and the prognosis G.; Sheijani, A.D.; Ziola, S.; Zentilin, of patients diagnosed with esophageal cancer remains poor, with an average survival rate of 5 years P.; De Marzo, M.G.; Giannini, E.G.; for only 20%.